NeurogesX Inc (fka NGSX)

[mlkrborn]

Recent developments: Note FDA datelines. Marc 7 was a crucial date for FDA's decision.

March 8, 2012
7:40a
NeurogesX: Believes 20% Capsaicin Formulation Of NGX-1998 May Provide Similar Efficacy, Safety As Qutenza (Dow Jones)
7:39a
NeurogesX: Received Complete Response Letter On Qutenza From FDA (Dow Jones)
7:39a
NeurogesX: Needs To Submit Addl Clinical Data To Get FDA Approval For Qutenza (Dow Jones)
7:39a
NeurogesX: Doesn't Anticipate Investing In Further Clinical Studies For Qutenza At This Time (Dow Jones)


March 14, 2012
12:35p
NeurogesX Raised To Outperform From Neutral By Wedbush >NGSX (Dow Jones)
March 8, 2012
7:40a
NeurogesX: Believes 20% Capsaicin Formulation Of NGX-1998 May Provide Similar Efficacy, Safety As Qutenza (Dow Jones)
7:39a
NeurogesX: Received Complete Response Letter On Qutenza From FDA (Dow Jones)
7:39a
NeurogesX: Needs To Submit Addl Clinical Data To Get FDA Approval For Qutenza (Dow Jones)
7:39a
NeurogesX: Doesn't Anticipate Investing In Further Clinical Studies For Qutenza At This Time (Dow Jones)
7:37a
NeurogesX Intends To Cut Estimated 2012 Cash Burn Rate To Between $5.5M-$6.5M/Qtr (Dow Jones)
7:37a
NeurogesX 2011-End Cash, Equivalents, S/T Investments $34.3M >NGSX (Dow Jones)
7:36a
NeurogesX Sees 2012 Oper Expenses Ex-Noncash Stk Expenses Cut By 32% From Prior Levels (Dow Jones)
7:35a
NeurogesX To Cut 57% Of Work Force >NGSX (Dow Jones)
7:33a
NeurogesX: Goal Is To Complete Required Initiatives To Prepare For Initiation Of A Ngx-1998 Phase 3 Clinical Trial Yr-End (Dow Jones)
7:33a
NeurogesX To Focus On Securing Addl Resources To Provide Cap To Complete NGX-1998 Trial (Dow Jones)
7:32a
NeurogesX To Restructure Ops To Minimize Cash Burn, Align Comml Ops Spending (Dow Jones)
7:30a
NeurogesX Reports Fourth Quarter and Year-End 2011 Results (GlobeNewswire)
7:30a
NeurogesX 4Q Loss/Shr 34c >NGSX (Dow Jones)
7:30a
NeurogesX 4Q Rev $2.96M >NGSX (Dow Jones)
February 29, 2012
8:30a
NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Full Year 2011 Results (GlobeNewswire)